• Ovarian cancer therapeutic advances earn support from Genelux in patient-focused collaboration Traders Union Mon, 06 Jul 2026 17:40:55 GMT
• gnlx q1 2026 earnings: eps misses estimates as clinical-stage biotech continues investment in pipeline dars.gov.et Thu, 02 Jul 2026 22:31:08 GMT
• GENELUX (NASDAQ: GNLX) director sells 12,000 shares to cover RSU tax bill Stock Titan Thu, 02 Jul 2026 20:35:51 GMT
• Form 144 GENELUX CORPORATION For: 1 July By Investing.com Investing.com Canada Wed, 01 Jul 2026 22:36:48 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Wed, 01 Jul 2026 13:22:00 GMT
• Lake Street Maintains Genelux(GNLX.US) With Buy Rating, Maintains Target Price $16 Moomoo Wed, 01 Jul 2026 01:38:19 GMT
• Genelux publishes results from Phase 1b 2 trial of Olvi Vec in ovarian cancer Traders Union Tue, 30 Jun 2026 12:25:17 GMT
• Genelux Announces Publication of Translational Analysis GlobeNewswire Tue, 30 Jun 2026 12:00:00 GMT
• Genelux says Olvi-Vec may reawaken platinum response in ovarian cancer Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• genelux corporation(nasdaqcm:gnlx) added to russell microcap value benchmark index marketscreener.com Mon, 29 Jun 2026 16:36:06 GMT
• lake street maintains genelux(gnlx.us) with buy rating, maintains target price $16 富途牛牛 Mon, 29 Jun 2026 10:13:01 GMT
• GNLX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances Pipeline - Profit Inflection Point dars.gov.et Mon, 29 Jun 2026 07:00:00 GMT
• genelux corporation(nasdaqcm: gnlx) added to russell 3000e value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• enterprise value to ebit forward of genelux corporation – nasdaq:gnlx TradingView Sat, 27 Jun 2026 01:53:59 GMT
• Price to sales forward of Genelux Corporation – NASDAQ:GNLX TradingView Sat, 27 Jun 2026 00:54:26 GMT
• enterprise value to revenue forward of genelux corporation – nasdaq:gnlx TradingView Fri, 26 Jun 2026 23:23:53 GMT
• genelux corp (gnlx) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• genelux corporation 8-k filing: company details, nasdaq listing, and emerging growth status (june 2026) Minichart Tue, 23 Jun 2026 02:28:00 GMT
• form 8k genelux corp for: 22 june by investing.com Investing.com Canada Mon, 22 Jun 2026 20:53:13 GMT
• Genelux elects director and ratifies auditor at annual shareholder meeting Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Genelux (GNLX) 2026 meeting backs director John Smither and auditor Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• GNLX Q1 2026 Earnings: Wider-than-Expected Loss Reflects Development Stage Costs - Forward Guidance Trends dars.gov.et Mon, 22 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 13:03:26 GMT
• Genelux (GNLX) director receives RSU and stock option grants Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• GENELUX (GNLX) CFO receives 278,906 restricted stock units as equity grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• GENELUX (NASDAQ: GNLX) director James L. Tyree receives RSU and option grants Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Genelux (NASDAQ: GNLX) grants CEO 730,601 RSUs under 2022 plan Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• GENELUX (NASDAQ: GNLX) director granted RSUs and options in new equity awards Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• GENELUX (GNLX) Chief Scientific Officer awarded 119,318 RSUs in equity grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• GENELUX (GNLX) CTO granted 174,841 RSUs under 2022 equity plan Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Genelux (GNLX) director receives RSUs and stock options in new grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• genelux (nasdaq: gnlx) grants 233,957 rsus to general counsel eric groen Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Genelux Corp (GNLX) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 06:56:21 GMT
• genelux corp (gnlx) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 06:55:11 GMT
• genelux corp (gnlx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 06:25:18 GMT
• genelux corp (gnlx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 19:31:37 GMT
• genelux corp (gnlx) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 19:31:35 GMT
• genelux corp (gnlx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 19:25:16 GMT
• genelux corp (gnlx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:53:25 GMT
• genelux corp (gnlx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• gnlx: director and auditor ratified; no questions or additional proposals raised TradingView Tue, 16 Jun 2026 15:34:43 GMT
• gnlx: director and auditor ratification proposals were approved without shareholder questions TradingView Tue, 16 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• genelux corp (gnlx) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• gnlx q1 2026 earnings: eps misses estimates as clinical-stage biotech continues r&d focus - margin guidance newsline.com Sat, 13 Jun 2026 15:44:25 GMT
• genelux corporation (gnlx) shows uptick: testing key resistance at $3.13 - straddle setup newsline.com Tue, 09 Jun 2026 23:43:22 GMT
• genelux corporation (gnlx) fades amid heightened selling pressure, approaches key support - high beta stocks newsline.com Sun, 07 Jun 2026 17:46:46 GMT
• genelux head of regulatory ralph smalling sells $562 in stock by investing.com Investing.com Australia Fri, 05 Jun 2026 01:14:35 GMT
• tax-related share sale by genelux (gnlx) head of regulatory Stock Titan Fri, 05 Jun 2026 00:49:49 GMT
• Genelux head of regulatory Ralph Smalling sells $562 in stock Investing.com Thu, 04 Jun 2026 07:00:00 GMT
• Tax-related share sale by Genelux (GNLX) Head of Regulatory Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• insider sell: john thomas sells 10,000 shares of genelux corp (g GuruFocus Wed, 03 Jun 2026 06:11:15 GMT
• genelux director thomas john sold $29,801 in company stock by investing.com Investing.com South Africa Wed, 03 Jun 2026 01:58:16 GMT
• genelux (nasdaq: gnlx) director sells 10,000 shares in rule 10b5-1 trade Stock Titan Wed, 03 Jun 2026 00:57:01 GMT
• Genelux director Thomas John sold $29,801 in company stock Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• genelux (nasdaq: gnlx) director sells 10,000 shares in rule 10b5-1 trade Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• GNLX (NASDAQ) director sells 10,000 shares via 10b5-1, $28,957 proceeds Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• genelux corporation (gnlx) declines 2.95% as support near $2.81 tested; resistance at $3.11 holds - inverse etf flow lwvtexas.org Mon, 01 Jun 2026 07:00:00 GMT
• gnlx q1 2026 earnings: eps miss amid pre-revenue development stage; stock edges higher - healthcare earnings report newsline.com Thu, 28 May 2026 07:00:00 GMT
• Genelux Corporation (GNLX) Edges Higher, Approaching Key Resistance Level - PCR Mean Reversion dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• patient-focused design drives engagement in onprime cancer trial Traders Union Wed, 27 May 2026 07:00:00 GMT
• gnlx q1 2026 earnings: eps misses estimates as company reports no revenue - earnings risk report The Legal Advocate Mon, 25 May 2026 07:32:42 GMT
• number of shareholders of genelux corporation – nasdaq:gnlx TradingView Sun, 24 May 2026 13:47:33 GMT
• gnlx q1 2026 earnings: wider-than-expected loss as pre-revenue biotech advances pipeline - retail earnings report Newser Sat, 23 May 2026 20:30:08 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Thu, 21 May 2026 07:00:00 GMT
• genelux corporation (gnlx) stock today: rallies +3.93%, resistance at $3.06 2026-05-20 - buffered etf newsline.com Wed, 20 May 2026 07:00:00 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Fri, 15 May 2026 07:00:00 GMT
• genelux president and ceo zindrick thomas sells $8,225 in stock by investing.com Investing.com South Africa Wed, 13 May 2026 07:00:00 GMT
• genelux cto joseph cappello sells $1,799 in company stock by investing.com Investing.com UK Wed, 13 May 2026 07:00:00 GMT
• genelux head of regulatory sells $804 in stock by investing.com Investing.com Australia Wed, 13 May 2026 01:04:32 GMT
• genelux cso yu yong sells $1,798 of common stock by investing.com Investing.com UK Wed, 13 May 2026 00:36:00 GMT
• genelux (gnlx) cso yu yong sells 605 shares to cover rsu tax bill Stock Titan Wed, 13 May 2026 00:33:15 GMT
• genelux (gnlx) head of regulatory sells 270 shares to cover rsu taxes Stock Titan Wed, 13 May 2026 00:33:15 GMT
• genelux (gnlx) ceo zindrick sells 2,798 shares for rsu tax obligations Stock Titan Wed, 13 May 2026 00:33:15 GMT
• genelux (gnlx) cto sells 605 shares to cover rsu tax obligations Stock Titan Wed, 13 May 2026 00:33:15 GMT
• research analysts offer predictions for genelux q2 earnings MarketBeat Tue, 12 May 2026 12:05:17 GMT
• hc wainwright has positive forecast for genelux q3 earnings MarketBeat Tue, 12 May 2026 12:03:30 GMT
• Genelux president and CEO Zindrick Thomas sells $8,225 in stock Investing.com Tue, 12 May 2026 07:00:00 GMT
• Genelux CTO Joseph Cappello sells $1,799 in company stock Investing.com Tue, 12 May 2026 07:00:00 GMT
• genelux (gnlx) cso yu yong sells 605 shares to cover rsu tax bill Stock Titan Tue, 12 May 2026 07:00:00 GMT
• genelux (gnlx) cto sells 605 shares to cover rsu tax obligations Stock Titan Tue, 12 May 2026 07:00:00 GMT
• genelux (gnlx) ceo zindrick sells 2,798 shares for rsu tax obligations Stock Titan Tue, 12 May 2026 07:00:00 GMT
• genelux (gnlx) head of regulatory sells 270 shares to cover rsu taxes Stock Titan Tue, 12 May 2026 07:00:00 GMT
• the hidden strength in genelux corporation (gnlx) most investors miss (slight dip) 2026-05-08 - social momentum signals newser.com Sat, 09 May 2026 02:35:43 GMT
• the hidden strength in genelux corporation (gnlx) most investors miss (slight dip) 2026-05-08 - seasonality effect newsline.com Fri, 08 May 2026 07:00:00 GMT
• genelux corporation reports first quarter financial results and provides business updates The Manila Times Fri, 08 May 2026 07:00:00 GMT
• lake street maintains genelux(gnlx.us) with buy rating, maintains target price $16 Moomoo Fri, 08 May 2026 07:00:00 GMT
• genelux corporation (gnlx) eps diluted (ttm) Zacks Investment Research Fri, 08 May 2026 06:17:52 GMT
• genelux reports q1 2026 financial results as late stage immuno oncology program advances Traders Union Thu, 07 May 2026 23:36:35 GMT
• genelux : quarterly report for quarter ending march 31, 2026 (form 10-q) marketscreener.com Thu, 07 May 2026 23:10:36 GMT
• genelux corp 1q 2026: revenue $0 net loss $8.9m, eps $(0.20) — 10-q summary TradingView Thu, 07 May 2026 20:11:00 GMT
• Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• genelux (gnlx) raises $18.5m, extends cash runway into 2027 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• ovarian cancer trial readout due in 2h26 as genelux cash lasts to 1q27 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• genelux corporation reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Thu, 07 May 2026 07:00:00 GMT
• gnlx stock price, quote & chart | genelux corp (nasdaq:gnlx) ChartMill Mon, 04 May 2026 07:00:00 GMT
• genelux corp expected to post a loss of 18 cents a share - earnings preview TradingView Fri, 01 May 2026 22:53:05 GMT
• genelux (nasdaq: gnlx) details 2026 virtual meeting, board and auditor votes Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• genelux (gnlx) expected to announce quarterly earnings on tuesday MarketBeat Tue, 28 Apr 2026 07:00:00 GMT
• gnlx (genelux corporation) rises 7.58 percent even as q4 2025 loss per share misses consensus estimates. - revenue growth Cổng thông tin điện tử tỉnh Lào Cai Thu, 23 Apr 2026 10:48:00 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Thu, 23 Apr 2026 07:00:00 GMT
• gnlx (genelux corporation) falls 2.46% after q4 2025 eps lands below analyst consensus estimates. - gamma squeeze Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 21:30:21 GMT
• gnlx (genelux corporation) rises 7.58 percent even as q4 2025 loss per share misses consensus estimates. - strategic review Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 17:36:14 GMT
• olvi vec could reshape advanced ovarian cancer treatment, genelux claims Traders Union Wed, 22 Apr 2026 07:00:00 GMT
• genelux corporation (gnlx) sector trends | genelux corporation misses eps estimates by 12.3% - strong earnings momentum newsline.com Mon, 20 Apr 2026 07:00:00 GMT
• genelux corporation (gnlx) stock: technical signals (technical weakness) 2026-04-20 - put call ratio The Legal Advocate Mon, 20 Apr 2026 07:00:00 GMT
• genelux corporation misses eps estimates by 12.3% - analyst recommended stocks Newser Mon, 20 Apr 2026 07:00:00 GMT
• genelux advances next generation oncolytic immunotherapies for cancer treatment Traders Union Fri, 17 Apr 2026 15:55:48 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• gnlx (genelux corporation) falls 2.46% after q4 2025 eps lands below analyst consensus estimates. - financial data The Legal Advocate Thu, 16 Apr 2026 07:00:00 GMT
• gnlx (genelux corporation) rises 7.58 percent even as q4 2025 loss per share misses consensus estimates. - revenue guidance update... newsline.com Wed, 15 Apr 2026 07:00:00 GMT
• investment review: can genelux corporation be recession proof - weekly gains report & ai based buy and sell signals baoquankhu1.vn Mon, 13 Apr 2026 17:49:25 GMT
• gnlx technical analysis | trend, signals & chart patterns | genelux corp (nasdaq:gnlx) ChartMill Fri, 10 Apr 2026 07:00:00 GMT
• aug breakouts: can genelux corporation be recession proof - weekly stock analysis & expert verified stock movement alerts baoquankhu1.vn Thu, 09 Apr 2026 10:11:06 GMT
• is genelux corporation (gnlx) stock good for short term | price at $2.45, down 7.20% - time weighted price newsline.com Thu, 09 Apr 2026 07:00:00 GMT
• certain restricted stock units of genelux corporation are subject to a lock-up agreement ending on 9-apr-2026. marketscreener.com Thu, 09 Apr 2026 00:22:23 GMT
• certain warrants of genelux corporation are subject to a lock-up agreement ending on 9-apr-2026. marketscreener.com Thu, 09 Apr 2026 00:22:16 GMT
• certain options of genelux corporation are subject to a lock-up agreement ending on 9-apr-2026. marketscreener.com Thu, 09 Apr 2026 00:22:07 GMT
• certain common stock of genelux corporation are subject to a lock-up agreement ending on 9-apr-2026. marketscreener.com Thu, 09 Apr 2026 00:21:57 GMT
• certain common stock of genelux corporation are subject to a lock-up agreement ending on 9-apr-2026. marketscreener.com Wed, 08 Apr 2026 07:00:00 GMT
Genelux Corp.(NASDAQ:GNLX) 
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac...
Website: https://www.genelux.com
Founded: 2001
IPO Price: $6 (Jan 26, 2023)
Full Time Employees: 15
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends